vault backup: 2025-11-28 13:57:22
All checks were successful
Deploy Quartz site to GitHub Pages / build (push) Successful in 1m45s
All checks were successful
Deploy Quartz site to GitHub Pages / build (push) Successful in 1m45s
This commit is contained in:
219
content/Biokemi/Plasmidlabb/Plasmid Lab Part 1 OCR.md
Normal file
219
content/Biokemi/Plasmidlabb/Plasmid Lab Part 1 OCR.md
Normal file
@@ -0,0 +1,219 @@
|
|||||||
|
Recombinant DNA technology
|
||||||
|
Lecture by:
|
||||||
|
Anne Wöhr
|
||||||
|
anne.wohr@gu.se
|
||||||
|
|
||||||
|
Recombinant DNA technology
|
||||||
|
Molecular cloning Transformation Selection and
|
||||||
|
Replication
|
||||||
|
Performed during this lab
|
||||||
|
|
||||||
|
Plasmids
|
||||||
|
• Commonly found in bacteria as extra-chromosomal
|
||||||
|
circular dsDNA molecules
|
||||||
|
• Able to self-replicate during cell division
|
||||||
|
• Often carry beneficial genes like antibiotic resistance
|
||||||
|
• Bacteria can share genetic information through
|
||||||
|
plasmid transfer
|
||||||
|
By: Maya Kostman
|
||||||
|
How could this be useful for us?
|
||||||
|
|
||||||
|
Applications of recombinant DNA
|
||||||
|
technologies
|
||||||
|
Khan S., 2016
|
||||||
|
Biopharmaceuticals:
|
||||||
|
Vaccines eg hepatitis B vaccine
|
||||||
|
recombinant proteins eg Insulin (Diabetes), Factor VIII (hemophilia)
|
||||||
|
Genetically modified organisms:
|
||||||
|
Organisms that have been genetically modified to exhibit specific traits eg
|
||||||
|
herbicide-resistant crop plants
|
||||||
|
Gene Therapy:
|
||||||
|
In some genetic disorders, patients lack the functional form of a gene. Gene
|
||||||
|
therapy attempts to provide a normal copy of the gene to the cells of the
|
||||||
|
patient.
|
||||||
|
Gene Analysis:
|
||||||
|
build artificial, recombinant versions of genes that help understand how
|
||||||
|
genes in an organism function
|
||||||
|
|
||||||
|
• Scissors: DNA restriction enzymes (DNA digestion)
|
||||||
|
• Cutting sites: multiple cloning sites (MCS)
|
||||||
|
• Glue: DNA ligase (DNA ligation)
|
||||||
|
• Host: bacterial cells (Transformation)
|
||||||
|
• Environment: LB medium or LB agar plates (Culturing)
|
||||||
|
• Goal: making more identical copies, or expression (making proteins)
|
||||||
|
Toolbox for molecular cloning
|
||||||
|
|
||||||
|
✓ DNA molecule that acts as a vehicle to carry foreign genetic materials
|
||||||
|
into another cell, where it can be replicated or expressed.
|
||||||
|
Vectors
|
||||||
|
Ori (origin of replication):
|
||||||
|
Replication is initiated here, enabling the plasmid to reproduce itself.
|
||||||
|
MCS (multiple cloning site):
|
||||||
|
Short segment of DNA which contains many restriction sites. This
|
||||||
|
allows a piece of DNA to be inserted into that region. The used
|
||||||
|
plasmid contains a BamHI cleavage site in its MCS.
|
||||||
|
AmpR gene:
|
||||||
|
encodes the enzyme beta-Lactamase, which inactivates ampicillin.
|
||||||
|
Cells containing a plasmid vector which expresses AmpR can be
|
||||||
|
selected from those that do not by growth in an ampicillin-containing
|
||||||
|
medium.
|
||||||
|
Lac promoter:
|
||||||
|
binding site of RNA polymerase to initiate expression. IPTG binds
|
||||||
|
and inactivates the LacI repressor protein and thereby enables
|
||||||
|
expression of genes downstream of the promoter.
|
||||||
|
LacZ⍺ gene:
|
||||||
|
encodes the alpha-peptide of the enzyme beta-galactosidase.
|
||||||
|
Functional beta-galactosidase consits of the alpha- and omega-
|
||||||
|
peptide. The used E-coli strain carries the lacZ deletion mutant
|
||||||
|
which contains the omega-peptide but lacks the alpha-peptide. The
|
||||||
|
activity of mutant beta-galactosidase is rescued by the presence of
|
||||||
|
the alpha-peptide present in the plasmid (alpha-complementation).
|
||||||
|
|
||||||
|
Restriction enzymes (Scissors)
|
||||||
|
✓ Sequence-specific DNA endonucleases
|
||||||
|
✓ Recognise and cleave DNA sequences at specific restriction sites
|
||||||
|
✓ Generate “sticky end” or “blunt end”
|
||||||
|
|
||||||
|
Escherichia coli (Host)
|
||||||
|
✓ Model organism in molecular biology
|
||||||
|
✓ Gram negative, rod shaped bacteria
|
||||||
|
✓ Located in lower intestine
|
||||||
|
|
||||||
|
The History of Insulin Production
|
||||||
|
1921: Discovery of insulin
|
||||||
|
1922: Leonard Thompson became the first person with diabetes ever
|
||||||
|
treated through administration of insulin
|
||||||
|
1923: Insulin is commercialized
|
||||||
|
Insulin sales kit, Eli Lilly and Company, 1940s
|
||||||
|
14 cows or 70 pigs to sustain a diabetic
|
||||||
|
patient for 1 year
|
||||||
|
1970: Recombinant DNA technology is
|
||||||
|
developed
|
||||||
|
1982: Recombinant insulin is commercialized
|
||||||
|
|
||||||
|
Production of Insulin
|
||||||
|
Adapted from “From DNA to Beer: Harnessing Nature in Medicine & Industry”
|
||||||
|
|
||||||
|
Purpose of this lab:
|
||||||
|
Determine whether a gene of interest has
|
||||||
|
been successfully cloned into a vector.
|
||||||
|
|
||||||
|
Transformation
|
||||||
|
|
||||||
|
Transformation
|
||||||
|
During the incubation
|
||||||
|
on ice, DNA binds to
|
||||||
|
the surface of the
|
||||||
|
bacterium as a calcium-
|
||||||
|
phosphate-DNA
|
||||||
|
complex
|
||||||
|
Following a sudden
|
||||||
|
increase in
|
||||||
|
temperature, one or
|
||||||
|
more DNA molecules
|
||||||
|
bound to the surface of
|
||||||
|
the cell is taken up by
|
||||||
|
the competent cell
|
||||||
|
|
||||||
|
How can we selectively grow bacteria
|
||||||
|
that have taken up the plasmid?
|
||||||
|
|
||||||
|
Selection pressure
|
||||||
|
✓ ampR gene encodes for beta-lactamase
|
||||||
|
✓ Inactivates ampicilin antibiotics
|
||||||
|
✓ Only cells containing vector DNA will grow
|
||||||
|
in the presence of ampicilin
|
||||||
|
Selection based on antibiotic resistance
|
||||||
|
|
||||||
|
How do we select for bacteria with the plasmids
|
||||||
|
carrying the inserts?
|
||||||
|
By: Maya Kostman
|
||||||
|
|
||||||
|
More detailed info: thermofisher.com
|
||||||
|
LacZ gene naturally found in E. coli, encodes β-galactosidase.
|
||||||
|
We use an E.coli strain that carries the LacZ deletion mutant which
|
||||||
|
contains the omega-peptide but lacks the alpha-peptide and is therefore
|
||||||
|
non-functional. The plasmid we use carries the alpha-peptide, rescuing the
|
||||||
|
function of mutant beta-galactosidase.
|
||||||
|
Blue-white screening
|
||||||
|
|
||||||
|
Lab Schedule
|
||||||
|
• Monday (11/24)
|
||||||
|
Introductory lecture 12:15 – 13:00
|
||||||
|
Lab 13:15 – 14:00 Groups 1-19
|
||||||
|
Lab 14:15 – 15:00 Groups 20-38
|
||||||
|
• Tuesday (11/25)
|
||||||
|
Lab 11:15 – 11:45 Groups 1-19
|
||||||
|
Lab 12:00 – 12:30 Groups 20-38
|
||||||
|
• Wednesday (11/26) Groups 1-19
|
||||||
|
Introductory lecture 8:15 – 9:00
|
||||||
|
Lab 09:15 – 16:00
|
||||||
|
• Thursday (11/27) Groups 20-38
|
||||||
|
Introductory lecture 8:15 – 9:00
|
||||||
|
Lab 9:15 – 16:00
|
||||||
|
Deadline for submitting lab reports: 07/12/2025
|
||||||
|
|
||||||
|
Working in the lab
|
||||||
|
✓ Work in groups of 2 people, stick to your assigned partner
|
||||||
|
✓ Always wear gloves and lab coat to protect you and your samples,
|
||||||
|
wash your hands thoroughly before leaving the lab
|
||||||
|
✓ When using the pipette, check the volume limits (0.1-10μl, 10-200μl,
|
||||||
|
and 100-1000μl)
|
||||||
|
✓ Pipette into the bottom of the tube, do not ”shoot” it (especially when
|
||||||
|
working with very low volumes)
|
||||||
|
|
||||||
|
Transformation of competent cells
|
||||||
|
→ performed during this lab (day 1)
|
||||||
|
✓ 1 tube of plasmids (P) (with/without insert)
|
||||||
|
✓ 1 tube of competent bacteria (C)
|
||||||
|
|
||||||
|
Day 1: Selection of transformed cells
|
||||||
|
→ performed during this lab (day 1)
|
||||||
|
✓ Pick up bacterial colonies (2 white, 2 blue) from plate
|
||||||
|
✓ Grow in LB medium with antibiotics (expand the colony and replicate plasmids)
|
||||||
|
Day 2: Picking & expansion of blue and white
|
||||||
|
colonies
|
||||||
|
→ performed during this lab (day 2)
|
||||||
|
|
||||||
|
Day 1: Materials for Transformation
|
||||||
|
Falcon tube (50ml) LB-agar plate Eppendorf tube
|
||||||
|
Day 1: Spread plate method
|
||||||
|
o Apply light pressure to not tear or stab the agar
|
||||||
|
|
||||||
|
Day 3 - work overview
|
||||||
|
✓ Purify plasmids
|
||||||
|
✓ Restriction enzyme digestion
|
||||||
|
✓ Run on agarose gel
|
||||||
|
✓ Interpret results
|
||||||
|
|
||||||
|
Lab reports
|
||||||
|
✓ Write according to the guidelines on the handout on Canvas
|
||||||
|
✓ One lab report per group (your names and project group number on
|
||||||
|
the cover page)
|
||||||
|
✓ In English
|
||||||
|
✓ Upload your lab reports on CANVAS deadline on 07/12/2025
|
||||||
|
|
||||||
|
Lecture Questions
|
||||||
|
1. Name three applications of molecular cloning.
|
||||||
|
2. What is a plasmid?
|
||||||
|
3. Name the three main steps involved in recombinant DNA technology?
|
||||||
|
4. What is a restriction enzyme?
|
||||||
|
5. What are the bacteria used in your protocol?
|
||||||
|
6. Explain the calcium/phosphate (heat-shock) method and what it is used for.
|
||||||
|
7. How can we selectively grow bacteria that have taken up the plasmid?
|
||||||
|
8. Explain the principle behind blue and white screening and its purpose in this
|
||||||
|
lab.
|
||||||
|
|
||||||
|
References
|
||||||
|
Kehoe A (1989). "The story of biosynthetic human insulin". In Sikdar SK, Bier M, Todd PW (eds.).
|
||||||
|
Frontiers in Bioprocesssing. Boca Raton, FL: CRC Press. ISBN 978-0-8493-5839-5.
|
||||||
|
https://www.sigmaaldrich.com/SE/en/technical-documents/technical-article/genomics/cloning-and
|
||||||
|
expression/blue-white-screening
|
||||||
|
https://www.nlm.nih.gov/exhibition/fromdnatobeer/exhibition-interactive/recombinant
|
||||||
|
DNA/recombinant-dna-technology-alternative.html
|
||||||
|
Khan, S., Ullah, M. W., Siddique, R., Nabi, G., Manan, S., Yousaf, M., & Hou, H. (2016). Role of
|
||||||
|
Recombinant DNA Technology to Improve Life. International journal of genomics, 2016, 2405954.
|
||||||
|
https://doi.org/10.1155/2016/2405954
|
||||||
|
https://www.thermofisher.com/se/en/home/life-science/cloning/cloning-learning-center/invitrogen
|
||||||
|
school-of-molecular-biology/molecular-cloning/cloning/traditional-cloning-basics.html
|
||||||
|
|
||||||
187
content/Biokemi/Plasmidlabb/Plasmid Lab Part 2 OCR.md
Normal file
187
content/Biokemi/Plasmidlabb/Plasmid Lab Part 2 OCR.md
Normal file
@@ -0,0 +1,187 @@
|
|||||||
|
Recombinant DNA technology
|
||||||
|
Lecture by:
|
||||||
|
Anne Wöhr
|
||||||
|
anne.wohr@gu.se
|
||||||
|
|
||||||
|
Molecular Cloning
|
||||||
|
→ Performed beforehand (not done during this lab)
|
||||||
|
|
||||||
|
Molecular Cloning
|
||||||
|
→ Performed beforehand (not done during this lab)
|
||||||
|
We aim to isolate/separate
|
||||||
|
these two plasmids to
|
||||||
|
select the recombinant
|
||||||
|
plasmid and to verify the
|
||||||
|
presence of the gene of
|
||||||
|
interest
|
||||||
|
|
||||||
|
Day 1: Transformation of competent cells
|
||||||
|
→ performed during this lab (day 1)
|
||||||
|
|
||||||
|
Day 1: Selection of transformed cells
|
||||||
|
→ performed during this lab (day 1 + day 2)
|
||||||
|
|
||||||
|
Day 2: Picking & expansion of blue
|
||||||
|
and white colonies
|
||||||
|
→ performed during this lab (day 2)
|
||||||
|
|
||||||
|
Revision
|
||||||
|
Blue-white screening
|
||||||
|
Plasmid:
|
||||||
|
• AmpR: Ampicillin resistance (β-lactamase)
|
||||||
|
• LacZ: α-peptide for functional β-galactosidase
|
||||||
|
enzyme
|
||||||
|
• BamHI restriction site in LacZ gene for
|
||||||
|
insertion of DNA
|
||||||
|
Growth medium:
|
||||||
|
• Ampicillin: Only successfully transformed
|
||||||
|
bacteria carrying plasmids can survive in the
|
||||||
|
presence of ampicillin
|
||||||
|
• IPTG : activates transcription of the LacZ gene
|
||||||
|
by binding its repressor
|
||||||
|
• X-gal: β-galactosidase degrades X-gal. The
|
||||||
|
product has a blue colour!
|
||||||
|
|
||||||
|
Day 3 - work overview
|
||||||
|
✓ Purify plasmids
|
||||||
|
✓ Restriction enzyme digestion
|
||||||
|
✓ Run on agarose gel
|
||||||
|
✓ Interpret results
|
||||||
|
|
||||||
|
Day 3: Material
|
||||||
|
Spin column
|
||||||
|
Tubes labeled with
|
||||||
|
A1; A2; A3; A4; H2O
|
||||||
|
Plasmid preparation kit
|
||||||
|
Collection tube &
|
||||||
|
spin column (blue)
|
||||||
|
|
||||||
|
Day 3: Plasmid purification
|
||||||
|
→ performed during this lab (day 3)
|
||||||
|
Buffer A1 (Cell Suspension)
|
||||||
|
Tris/HCl (pH 8.0), EDTA, RNase A
|
||||||
|
Buffer A2 (Cell Lysis)
|
||||||
|
NaOH; SDS
|
||||||
|
Buffer A3 (Neutralization/Binding)
|
||||||
|
Contains acetate and guanidine
|
||||||
|
hydrochloride
|
||||||
|
Buffer A4 (Wash, reconstituted)
|
||||||
|
Contains ethanol, NaCl, EDTA, and
|
||||||
|
Tris/HCl
|
||||||
|
|
||||||
|
cells grown in LB-
|
||||||
|
media overnight
|
||||||
|
Transfer 2x 750 µl into
|
||||||
|
microcentrifuge tube
|
||||||
|
Bacterial pellet = cells + plasmid
|
||||||
|
→ Discard superatant
|
||||||
|
Balance the centrifuge
|
||||||
|
Day 3: harvest cells & purify plasmids
|
||||||
|
A1 - resuspension buffer
|
||||||
|
A2 – cell lysis buffer
|
||||||
|
A3 – neutralization/
|
||||||
|
binding buffer
|
||||||
|
Plasmid in supernatant
|
||||||
|
cell debris as pellet
|
||||||
|
transfer supernatant
|
||||||
|
to column
|
||||||
|
Plasmid binding
|
||||||
|
Discard
|
||||||
|
flow-through
|
||||||
|
Wash with A4
|
||||||
|
Transfer column to new tube
|
||||||
|
add H2O to elute plasmid
|
||||||
|
|
||||||
|
QIAprep Miniprep Handbook, Appendix A: Background Information, Preparation of cell lysates, p 43
|
||||||
|
Plasmid purification
|
||||||
|
Buffer A1:
|
||||||
|
Bacterial cells are resuspended in a buffer containing Rnase A.
|
||||||
|
Buffer A2:
|
||||||
|
Bacteria are lysed under alkaline conditions (NaOH). SDS solubilizes the phospholipid
|
||||||
|
and protein components of the cell membrane
|
||||||
|
Lysis and release of cells contents. Alkaline conditions: denaturation of chromosomal
|
||||||
|
and plasmid DNA as well as proteins.
|
||||||
|
Buffer A3:
|
||||||
|
The lysate is neutralized and adjusted to high-salt-binding conditions. The high salt
|
||||||
|
concentration causes denatured proteins, chromosomal DNA, cellular debris, and SDS
|
||||||
|
to precipitate, while the smaller plasmid DNA renatures correctly and stays in solution.
|
||||||
|
DNA is bound to silica membrane of spin columns in high-salt buffer. RNA, cellular
|
||||||
|
proteins and metabolites are not retained on the membrane.
|
||||||
|
Buffer A4:
|
||||||
|
Washing and reconstitution of DNA. Salts are efficiently removed by this wash step.
|
||||||
|
H2O:
|
||||||
|
The purified plasmid DNA is eluted from silica membrane by addition of water. The
|
||||||
|
elution is pe is dependent on a low salt concentration and a stable pH (pH 7-8.5).
|
||||||
|
|
||||||
|
Restriction enzyme working solution:
|
||||||
|
Restriction enzyme buffer
|
||||||
|
H2O
|
||||||
|
Restriction enzyme (keep it cold!)
|
||||||
|
Add restriction enzyme to a portion of eluted plasmid
|
||||||
|
KEEP THE REST OF UNDIGESTED PLASMID AS CONTROLS FOR
|
||||||
|
LATER USE Incubate at 37°C for 60 min
|
||||||
|
Day 3: Restriction enzyme digestion
|
||||||
|
|
||||||
|
Day 3: Restriction enzyme digestion
|
||||||
|
Plasmid without insert (2700 bp)
|
||||||
|
Plasmid with insert in BamHI site (4200 bp)
|
||||||
|
Cut with BamHI → bands at 2700 bp and 1500 bp
|
||||||
|
|
||||||
|
• Samples are mixed with 6x loading
|
||||||
|
dye to make them ”heavier” to stay
|
||||||
|
in wells
|
||||||
|
• Separation of DNA molecules
|
||||||
|
based on their size
|
||||||
|
• DNA negatively charged
|
||||||
|
• Agarose gel for separation
|
||||||
|
• Shorter molecules move faster and
|
||||||
|
migrate farther than longer ones
|
||||||
|
• Visualization of DNA with SYBR
|
||||||
|
safe DNA stain
|
||||||
|
Day 3: Agarose Gel Electrophoresis
|
||||||
|
|
||||||
|
GeneRuler 1kb DNA ladder = size marker
|
||||||
|
marker
|
||||||
|
2700 bp
|
||||||
|
1500 bp
|
||||||
|
4200 bp
|
||||||
|
Day 3: Expected Results
|
||||||
|
|
||||||
|
• Relaxed/linear: intact circle but “nick” in one strand
|
||||||
|
• Linear: both strands are cut (at the same location)
|
||||||
|
• Supercoiled: fully intact with both strands uncut, appears in a compact
|
||||||
|
form
|
||||||
|
Plasmid conformation affects migration
|
||||||
|
|
||||||
|
Lab schedule
|
||||||
|
✓ Purify plasmids
|
||||||
|
✓ Restriction enzyme digestion
|
||||||
|
1-2h incubation time → lunchbreak and
|
||||||
|
everyone will be back at the same time
|
||||||
|
✓ Run on agarose gel
|
||||||
|
approximately 1h → go through the
|
||||||
|
expected results to be able to ask
|
||||||
|
appropriate questions
|
||||||
|
✓ Interpret results
|
||||||
|
make sure to ask a lot of questions while you have
|
||||||
|
the chance!!!
|
||||||
|
|
||||||
|
Lab reports
|
||||||
|
✓ Write according to the guidelines on the handout on Canvas
|
||||||
|
✓ One lab report per group (Names and group number on the cover page)
|
||||||
|
✓ In English
|
||||||
|
✓ Upload your lab reports on CANVAS, deadline 07/12/2025
|
||||||
|
|
||||||
|
Lecture Questions
|
||||||
|
1. What are the sites the plasmid contains that allow for this experiment?
|
||||||
|
2. What are the 3 compounds in the LB plates that allow for selection of
|
||||||
|
bacteria with plasmid and the distinction of plasmids with and without
|
||||||
|
the inserted gene?
|
||||||
|
3. What are the six steps in plasmid preparation and purification?
|
||||||
|
4. What is a restriction enzyme and why was it used in this experiment?
|
||||||
|
5. Explain the principle of Gel Electrophoresis, what is it for?
|
||||||
|
6. What´s the compound that allows for the visualization of the DNA in
|
||||||
|
the gel?
|
||||||
|
7. How many times does BamHI cut the plasmid without the insert? And
|
||||||
|
the plasmid with the insert?
|
||||||
|
8. Explain the different plasmid conformations that exist.
|
||||||
Reference in New Issue
Block a user